SciELO - Scientific Electronic Library Online

 
vol.31 issue4Hematologic manifestations, pathogenesis and laboratory tests in Ebola virus disease author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Hematología, Inmunología y Hemoterapia

On-line version ISSN 1561-2996

Abstract

BLANQUICETH M, Yurany; RODRIGUEZ P, Ana Lucía; MONTOYA G, Carlos Julio  and  VELILLA H, Paula Andrea. Induction of regulatory T cells by statins: alternative therapy for the control of extrinsic asthma. Rev Cubana Hematol Inmunol Hemoter [online]. 2015, vol.31, n.4, pp. 0-0. ISSN 1561-2996.

Extrinsic asthma is caused by an immunological type I hypersensitivity reaction triggered mainly by environmental allergens. Usually, immune response mediated mainly by CD4 + T cells with Th2 profile determines the main features of extrinsic asthma, including infiltration of eosinophils and basophils that mediate chronic inflammation of the airways. It has been observed that regulatory T cells may act as endogenous modulators during asthmatic processes, controlling crisis exacerbation and decreasing tissue damage. Although glucocorticoids are the main treatment for asthma, these only relieve symptoms temporarily and are associated with adverse effects and development of resistance, which has encouraged the development of alternative therapies that modulate the immune response and control chronic inflammation. Recently, it has been postulated that statins may be a promising alternative to reduce the inflammatory response and decrease the morbidity associated with this disease, due to its great immunomodulator potential, especially in the induction of regulatory T cells.

Keywords : extrinsic asthma; regulatory T cells; FOXP3; statins; immunomodulation.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License